Quiz: Pharmacy Law and Professional Standards — 21 questions

1. Which condition characterized drug use and medicine claims in the United States during the nineteenth century?

A. Medicines were widely regulated through federal safety laws

B. Opium was used in medications amid weak regulation and unsupported claims

C. Professional organizations verified most therapeutic claims before sale

D. State agencies required scientific evidence for every medicine marketed

Answer: (B)

Explanation

Nineteenth-century U.S. medicines were largely unregulated, opium commonly appeared in medications, and many products made scientifically unsupported claims. The idea that agencies verified most claims describes a later period of stronger oversight, not the nineteenth century.

2. What development did drug-related injuries and deaths help produce during the twentieth century?

A. The removal of consumer protections from medicine distribution

B. A return to informal medicine sales without oversight

C. The creation of laws, regulatory agencies, and professional organizations

D. The replacement of professional organizations by private manufacturers

Answer: (C)

Explanation

Drug injuries and deaths encouraged the development of laws, regulatory agencies, and professional organizations intended to protect consumers and regulate medicines. Informal sales and reduced protections would move in the opposite direction from this historical response.

3. Which group is part of the federal and state system for overseeing drugs and related health activities?

A. The Federal Reserve and municipal planning commissions

B. The Food and Drug Administration and state boards of health

C. The Department of Education and local library authorities

D. The National Park Service and state transportation departments

Answer: (B)

Explanation

The Food and Drug Administration and state boards of health are among the bodies involved in federal and state oversight. The other combinations involve agencies whose primary responsibilities are unrelated to drug and health oversight.

4. Which organization is specifically included among bodies involved in drug and health oversight?

A. United States Postal Service

B. Department of Housing and Urban Development

C. Federal Trade Commission

D. National Aeronautics and Space Administration

Answer: (C)

Explanation

The Federal Trade Commission is listed among organizations involved in oversight alongside agencies such as the FDA, DEA, OSHA, and CDC. The other agencies have important governmental roles but are not identified here as members of this oversight group.

5. What distinguishes a law from a regulation in governmental oversight?

A. A law is a legislative rule, while a regulation carries that rule out

B. A law is an agency procedure, while a regulation expresses personal conduct

C. A law is a professional benchmark, while a regulation is an ethical code

D. A law is a quality target, while a regulation measures workplace performance

Answer: (A)

Explanation

Laws are broad rules passed by legislative branches, whereas regulations provide rules and procedures for carrying those laws out. Quality benchmarks and professional conduct codes correspond more closely to standards and ethics than to laws.

6. A government agency creates procedures to implement a statute governing medicines. What type of oversight do these procedures represent?

A. Standards

B. Laws

C. Professional ethics

D. Regulations

Answer: (D)

Explanation

Procedures created to implement a statute are regulations because regulations carry laws into effect. The statute itself would be the law, while standards and ethics address quality benchmarks and professional conduct.

7. What does a standard establish in professional or product oversight?

A. A procedure designed to implement a statute

B. A code requiring high professional conduct

C. A legislative rule passed by a government branch

D. A benchmark for desired quality or performance

Answer: (D)

Explanation

A standard sets a benchmark or desired normal level for product quality or professional performance. Legislative rules are laws, implementation procedures are regulations, and high-conduct codes represent professional ethics.

8. Which situation best illustrates professional ethics in pharmacy practice?

A. Following a code of high professional standards

B. Complying with a rule passed by legislators

C. Meeting a benchmark for product quality

D. Applying procedures created under a statute

Answer: (A)

Explanation

Professional ethics involves following a code of high professional standards that guides conduct within the profession. Product benchmarks are standards, statutory procedures are regulations, and rules passed by legislators are laws.

9. What major change did the Food, Drug, and Cosmetic Act of 1938 introduce?

A. It required most medications to be dispensed in child-resistant containers.

B. It required generic manufacturers to prove bioequivalence to brand products.

C. It classified drugs with abuse potential into five restriction schedules.

D. It required manufacturers to obtain approval before releasing a new drug.

Answer: (D)

Explanation

The 1938 Act required pharmaceutical manufacturers to obtain approval before releasing a new drug and established the Federal Food and Drug Administration. Drug scheduling, packaging, and generic bioequivalence were addressed by different federal laws.

10. A law classifies drugs into five schedules according to abuse-related restrictions. Which law is being applied?

A. The Controlled Substances Act of 1970

B. The Poison Prevention Packaging Act of 1970

C. The Hatch-Waxman Act of 1984

D. The Food, Drug, and Cosmetic Act of 1938

Answer: (A)

Explanation

The Controlled Substances Act classified drugs with abuse potential into five schedules with different levels of restriction. The Food, Drug, and Cosmetic Act concerns approval before release rather than abuse-related scheduling.

11. Which federal agency can change a drug’s schedule, as occurred with hydrocodone combination products in 2014?

A. The United States Pharmacopeia

B. The Occupational Safety and Health Administration

C. The Federal Food and Drug Administration

D. The Drug Enforcement Administration

Answer: (D)

Explanation

The Drug Enforcement Administration can classify new drugs or change existing schedules, including the 2014 move of hydrocodone combination products from Schedule III to Schedule II. The FDA approves drugs, while the USP establishes practice standards.

12. What was the primary purpose of the Poison Prevention Packaging Act of 1970?

A. To require approval before manufacturers released newly developed drugs

B. To establish bioequivalence requirements for generic medications

C. To reduce accidental childhood poisonings through child-resistant packaging

D. To classify medications according to their potential for abuse

Answer: (C)

Explanation

The Act generally required prescription and over-the-counter drugs to be packaged in child-resistant containers to help prevent accidental childhood poisonings. It did not establish drug approval, scheduling, or generic bioequivalence rules.

13. What role does the USP-NF play in pharmacy practice?

A. It sets standards for practice by pharmacists and pharmacy technicians.

B. It approves new drugs before manufacturers release them to patients.

C. It assigns controlled substances to schedules based on abuse potential.

D. It requires generic manufacturers to demonstrate brand-name bioequivalence.

Answer: (A)

Explanation

The USP-NF is a key pharmacy resource that sets standards for pharmacy practice by pharmacists and pharmacy technicians. Federal laws handle drug approval, controlled-substance scheduling, and generic-drug requirements.

14. Which USP-NF chapter addresses standards for nonsterile compounding?

A. General Chapter <900>

B. General Chapter <795>

C. General Chapter <797>

D. General Chapter <800>

Answer: (B)

Explanation

USP-NF General Chapter <795> addresses nonsterile compounding standards. Chapter <797> concerns sterile compounding, while Chapter <800> addresses hazardous substances in compounding.

15. A pharmacy is reviewing standards for preparing sterile compounded medications. Which USP-NF chapter is most relevant?

A. General Chapter <900>

B. General Chapter <800>

C. General Chapter <795>

D. General Chapter <797>

Answer: (D)

Explanation

USP-NF General Chapter <797> addresses sterile compounding standards. Chapter <795> applies to nonsterile compounding, whereas Chapter <800> focuses on hazardous substances.

16. Which compounding issue is addressed by USP General Chapter <800>?

A. Preparing nonsterile compounds under pharmacy practice standards

B. Approving new medications before commercial distribution

C. Handling hazardous substances, including chemotherapy drugs

D. Preparing sterile compounds under pharmacy practice standards

Answer: (C)

Explanation

USP General Chapter <800> addresses the handling of hazardous substances in compounding, including chemotherapy drugs. Nonsterile and sterile compounding are covered by Chapters <795> and <797>, respectively.

17. Which group shares legal responsibilities in pharmacy practice?

A. Hospital physicians, nurses, and medical equipment vendors

B. Drug manufacturers, patients, and insurance representatives

C. Federal legislators, wholesalers, and laboratory researchers

D. Facility managers, pharmacists, and pharmacy technicians

Answer: (D)

Explanation

Legal responsibilities in pharmacy practice apply to facility managers, pharmacists, and pharmacy technicians. The other groups may interact with pharmacy operations but are not the personnel group identified as sharing these responsibilities.

18. A pharmacy reviews whether workplace procedures meet legal obligations. Which personnel should be included in that review?

A. Drug manufacturers, wholesalers, and delivery contractors

B. Prescribers, patients, and health insurance auditors

C. Facility managers, pharmacists, and pharmacy technicians

D. Laboratory scientists, nurses, and medical billing staff

Answer: (C)

Explanation

Legal responsibilities in pharmacy practice extend across facility managers, pharmacists, and pharmacy technicians, so all three should be included in the review. Other healthcare or supply-chain participants may have separate duties but are not the personnel identified here.

19. A pharmacy professional is sued after a dispensing error allegedly causes financial and personal harm to a patient. Which legal category generally addresses this dispute between the parties?

A. Constitutional law, because the case concerns access to healthcare

B. Criminal law, because every dispensing error is treated as an offense

C. Civil law, because it concerns harm and a dispute between parties

D. Administrative law, because the dispute involves a regulated profession

Answer: (C)

Explanation

Civil law generally addresses disputes and alleged harm between parties, such as a patient seeking redress from a pharmacy professional. Criminal law instead concerns offenses prosecuted as violations of criminal statutes.

20. In a lawsuit involving a pharmacy, which party is the plaintiff?

A. The party who responds to the lawsuit

B. The lawyer who represents the pharmacy

C. The judge who presides over the case

D. The party who brings the lawsuit

Answer: (D)

Explanation

The plaintiff is the party that initiates a lawsuit against another party. The party responding to that lawsuit is the defendant, not the plaintiff.

21. A patient files a lawsuit against a pharmacist for alleged harm caused by professional negligence. Who is the defendant?

A. The patient who initiated the legal action

B. The pharmacist against whom the lawsuit is brought

C. The witness who describes the alleged harm

D. The court official assigned to hear the case

Answer: (B)

Explanation

The defendant is the party against whom a lawsuit is brought, which in this situation is the pharmacist. The patient who files the claim is the plaintiff.